178 related articles for article (PubMed ID: 6358156)
21. Reduced fractionation and the potential of hypoxic cell sensitizers in irradiation of malignant epithelial tumors.
Cox JD; Byhardt RW; Komaki R; Greenberg M
Int J Radiat Oncol Biol Phys; 1980 Jan; 6(1):37-40. PubMed ID: 6245044
[No Abstract] [Full Text] [Related]
22. Misonidazole in the preoperative and radical radiotherapy of bladder cancer.
Awwad HK; El Merzabani MM; El Badawy S; Ezzat S; Akoush H; Abd El Moneim H; Saiid A; Soliman O; Khafagy M; Burgers MV
Cancer Clin Trials; 1980; 3(3):275-80. PubMed ID: 7438324
[TBL] [Abstract][Full Text] [Related]
23. Irradiation with misonidazole and hyperbaric oxygen: final report on a randomized trial in advanced head and neck cancer.
Sealy R; Cridland S; Barry L; Norris R
Int J Radiat Oncol Biol Phys; 1986 Aug; 12(8):1343-6. PubMed ID: 3531113
[TBL] [Abstract][Full Text] [Related]
24. Combined treatment of radiation and local injections of misonidazole.
Hong SS; Abe Y; Kaneta K; Matsuzawa T
Int J Radiat Oncol Biol Phys; 1984 Dec; 10(12):2369-73. PubMed ID: 6511531
[TBL] [Abstract][Full Text] [Related]
25. [Radiosensitization of C3H/He mammary carcinoma by administration of hyperthermia and/or of misonidazole (author's transl)].
Suyama S; Yabumoto E; Furunishi H; Kawanishi K; Yamazaki T; Abe M
Nihon Igaku Hoshasen Gakkai Zasshi; 1981; 41(10):998-1003. PubMed ID: 7335473
[No Abstract] [Full Text] [Related]
26. A new approach to the use of misonidazole as a radiosensitizer of hypoxic tumour cells.
Abratt RP
Br J Cancer; 1982 Dec; 46(6):976-9. PubMed ID: 7150492
[No Abstract] [Full Text] [Related]
27. Hypoxic radiosensitizers in radical radiotherapy for patients with bladder carcinoma: hyperbaric oxygen, misonidazole, and accelerated radiotherapy, carbogen and nicotinamide.
Droller MJ
J Urol; 2000 May; 163(5):1600. PubMed ID: 10798919
[No Abstract] [Full Text] [Related]
28. The effect of hypoxic radiosensitizer after mild hyperthermia in C3H mammary carcinoma.
Ohizumi Y; Murayama C; Maezawa H; Mori T
Tokai J Exp Clin Med; 1984 Oct; 9(4):331-7. PubMed ID: 6537042
[TBL] [Abstract][Full Text] [Related]
29. [Clinical study on radiotherapy in combination with misonidazole].
Ono K; Takahashi M; Dodo Y; Abe M
Nihon Gan Chiryo Gakkai Shi; 1983 Aug; 18(5):1189-99. PubMed ID: 6663172
[No Abstract] [Full Text] [Related]
30. Experience in the radical radiotherapy of cancer in the bilharzial bladder: the use of misonidazole.
Awwad HK; Akhoush H; El-Merzabani M; El Badawy S; Barsoum M; el Baki HA
Radiother Oncol; 1984 Jun; 2(1):1-8. PubMed ID: 6095372
[TBL] [Abstract][Full Text] [Related]
31. A randomized study of misonidazole and radiotherapy for grade 3 and 4 cerebral astrocytoma.
Bleehen NM; Wiltshire CR; Plowman PN; Watson JV; Gleave JR; Holmes AE; Lewin WS; Treip CS; Hawkins TD
Br J Cancer; 1981 Apr; 43(4):436-42. PubMed ID: 7016157
[TBL] [Abstract][Full Text] [Related]
32. Radical irradiation and misonidazole in the treatment of T2 grade III and T3 bladder cancer.
Abratt RP; Sealy R; Tucker RD; Williams MA; Barnes DR; Johnson MB; Green JA; Cridland JS
Int J Radiat Oncol Biol Phys; 1983 May; 9(5):629-32. PubMed ID: 6853264
[TBL] [Abstract][Full Text] [Related]
33. Combinations of radiation and misonidazole in a murine lung tumor model.
Siemann DW; Kochanski K
Radiat Res; 1981 May; 86(2):387-97. PubMed ID: 7232698
[No Abstract] [Full Text] [Related]
34. Hypoxic cell sensitizers and heavy charged particle beams may play complementary roles in killing hypoxic tumor cells.
Curtis SB; Tenforde TS; Afzal SM
Int J Radiat Oncol Biol Phys; 1984 Aug; 10(8):1203-5. PubMed ID: 6432747
[TBL] [Abstract][Full Text] [Related]
35. Increasing radiation dose intensity using hyperfractionation in patients with malignant glioma. Final report of a prospective phase I-II dose response study.
Fulton DS; Urtasun RC; Scott-Brown I; Johnson ES; Mielke B; Curry B; Huyser-Wierenga D; Hanson J; Feldstein M
J Neurooncol; 1992 Sep; 14(1):63-72. PubMed ID: 1335044
[TBL] [Abstract][Full Text] [Related]
36. Clinical trials with cyclophosphamide and misonidazole combination for maintaining treatment after radiation therapy of lung carcinoma.
Busutti L; Breccia A; Stagni G; Gattavecchia E
Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1739-43. PubMed ID: 6480456
[TBL] [Abstract][Full Text] [Related]
37. The effect of prolonged high dose misonidazole on tumor response to radiation.
McNally NJ; de Ronde J; Hinchliffe M
Int J Radiat Oncol Biol Phys; 1984 Aug; 10(8):1281-5. PubMed ID: 6469751
[TBL] [Abstract][Full Text] [Related]
38. Palliation of advanced pelvic malignant disease with large fraction pelvic radiation and misonidazole: final report of RTOG phase I/II study.
Spanos WJ; Wasserman T; Meoz R; Sala J; Kong J; Stetz J
Int J Radiat Oncol Biol Phys; 1987 Oct; 13(10):1479-82. PubMed ID: 2442127
[TBL] [Abstract][Full Text] [Related]
39. Nitroheterocyclic compounds as radiation sensitizers and bioreductive drugs.
Adams GE; Stratford IJ; Bremner JC; Edwards HS; Fielden EM
Radiother Oncol; 1991; 20 Suppl 1():85-91. PubMed ID: 2020774
[No Abstract] [Full Text] [Related]
40. A randomized comparison of misonidazole sensitized radiotherapy plus BCNU and radiotherapy plus BCNU for treatment of malignant glioma after surgery: final report of an RTOG study.
Nelson DF; Diener-West M; Weinstein AS; Schoenfeld D; Nelson JS; Sause WT; Chang CH; Goodman R; Carabell S
Int J Radiat Oncol Biol Phys; 1986 Oct; 12(10):1793-800. PubMed ID: 3531110
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]